Navigation Links
Transgene's Therapeutic Vaccine TG4010 Shows Promising Preliminary Phase IIb Data in Advanced Non-Small Cell Lung Cancer
Date:1/10/2008

rter of 2008."

About TG4010 cancer vaccine

TG4010 (MVA-MUC1-IL2) uses the Modified Vaccinia Ankara virus vector, a poxvirus that combines distinguishing advantages for an optimized systemic vaccination:

- MVA is a highly attenuated strain which has been tested extensively in humans as a smallpox vaccine and is known to strongly stimulate the immune response to antigens.

- MUC1 is a major tumor-associated antigen that provides a viable target for vaccination.

- TG4010 expresses the entire MUC1 gene sequence and has the potential to generate an immune response to all antigenic epitopes of MUC1.

- The sequence coding for the cytokine Interleukin 2 (IL2) is included to help stimulate specific T-cell response.

About previous TG4010 clinical data

Non-controlled Phase II data are available at: http://www.transgene.fr/us/pdf/communique_presse/communiques_divers_2005/PR -U S_17-05-2005_ASCO_POUMON.pdf (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)

About Transgene

Transgene is a France-based biopharmaceutical company dedicated to the development of therapeutic vaccines and immunotherapeutic products in oncology and infectious diseases. The company has one product which has completed Phase II trials (TG4001/R3484), two compounds in Phase II trials (TG4010 and TG1042) and one compound in Phase I studies (TG4040). Transgene has concluded a strategic partnership agreement with Roche for the development of its TG4001/R3484 therapeutic vaccine to treat HPV-mediated diseases. Transgene has bio-manufacturing capacities for viral-based vectors and technologies available for out-licensing. Additional information about Transgene is available on the Internet at '/>"/>

SOURCE Transgene S.A.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
2. Mersana Therapeutics Appoints C. Boyd Clarke Chairman of the Board of Directors
3. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
4. Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
5. MultiCell Technologies To Increase Focus on Therapeutic Candidates
6. Sirnaomics Received Multiple Government Fundings For Its Multi-Targeted siRNA Therapeutics Programs
7. Co-Inventor of Amgens Aranesp(R) Technology Directs Worldwide Patent Strategy for Diffusion Pharmaceuticals First-in-Class Oxygen Enhancing Therapeutics
8. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
9. Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
10. House and Senate Pass Medicare Legislation to Freeze 2008 Reimbursement for Therapeutic Radiopharmaceuticals at 2007 Levels
11. Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2008).... 15 /- Quincy Bioscience (Madison, W...n.com ), a dietary supplement,consisting of the je...otential to improve memory in healthy human subjec...articipants that completed a 30-day open-label,stu...ntation with,apoaequorin, a well-known calcium-bin...
(Date:10/15/2008)...ance, October 15 /-, (EUR ... 08/07 EUR ... millions sales change millions ... 71 17 23.8 70 16 Other EU c... 25 21 Other markets 1.5 ...
(Date:10/15/2008)...lo., Oct. 15 /- Bolder BioTechnology,...1.6 million Phase II Continuing,Renewal Small Busi...ong-Acting Beta Interferon for Multiple Sclerosis"...rders and Stroke (NINDS) of The National,Institute...rd is contingent,upon the achievement of certain r...
(Date:10/15/2008)...moting its new PadLock Set Saver product at the Am...t Conference in Salt Lake City,UT, at The Salt Pa.... 15 /- Baxa Corporation is promoting...gnet Conference, October,15-17, in Salt Lake City...., PadLock provides a secure seal for the end of th...
Breaking Biology Technology:Jellyfish Protein Shows Potential to Help With Memory 2Jellyfish Protein Shows Potential to Help With Memory 3Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14% 2Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14% 3Bolder BioTechnology Receives $1.6 million NIH Grant to Continue Development of Multiple Sclerosis Drug 2Baxa Corporation Features PadLock(R) Set Saver at the ANCC National Magnet Conference(TM) 2
... Technology Network (WTN) just turned one! It is b...ee what we have accomplished in just 12 months of ...by Amazon and powered by Goggle) wistechnology.co... reach, and page views compared to other technolog...st. WTN is read beyond Wisconsin with 30% of its, ...
...over Spirit, which bounced to a near pinpoint land...Saturday (Jan. 3) after a seven-month flight, prom...Madison scientists say. , ,John Valley, a UW-Madis...ducted isotopic analyses of meteorites believed to...onsiderably to our knowledge of Mars and whether o...
...,Lets start with the good in Midwest biotech in 20...ormance of the publicly traded Midwest biotech com... Index, which evaluates the top 20 biotech stocks ...tellar performance of the Nasdaq and Amex Biotech ...lly ticked up even more in the last trading days o...
.... - GE Medical Systems and University Community H...ealth network based in Tampa, Florida have announc...dvanced heart hospitals. GE Medical Systems will...scular hospital, designed to deliver cardiovascula...hnology, when it opens in the spring of 2005. , ,...
Other Biology Technology:WTN's First Year 2The Good, Bad, Ugly of Midwest Biotech in 2003 2The Good, Bad, Ugly of Midwest Biotech in 2003 3GE Medical Enables Digital Heart Hospital 2GE Medical Enables Digital Heart Hospital 3
(Date:10/15/2008)..., Ulrike Gaul, professor of molecular biology at ... professor of theoretical physics at New York Univ...or the first Alexander von Humboldt professorships... (LMU) Mnchen nominated the two scientists for thi... by the Humboldt Foundation panel. This distinctio...
(Date:10/15/2008)..., Salk researcher Dr. Fred H. Gage, professor in ...eio Medical Science Prize for his discovery of the...lian brains. He will officially receive the award ...edicine in Japan on Nov. 21. , Dr. Gage,s labora...tem and unexpected plasticity and adaptability to ...
(Date:10/15/2008)..., Reston, VA (October 28, 2008) -- A study(1) pub...al, Toxicological Sciences, which is published b...cology, describes the kidney toxicity of melamine ...to characterize the toxicity of the compounds that...This research points to a possible link between th...
(Date:10/15/2008)..., As concerns about the effects of global warming...ecember issue of Physiological and Biochemical Zo...re of only two degrees Celsius could have a devast...kangaroos. , "Our study provides evidence that c...e range contractions, and the possible extinction ...
Breaking Biology News(10 mins):2 Alexander von Humboldt professorships go to LMU Munich 22 Alexander von Humboldt professorships go to LMU Munich 32 Alexander von Humboldt professorships go to LMU Munich 42 Alexander von Humboldt professorships go to LMU Munich 5Global warming threatens Australia's iconic kangaroos 2Study shows increased education on nanotech human enhancement increases public concerns 4070 1Study shows increased education on nanotech human enhancement increases public concerns 4070 2Assurant Health Names Jennifer Kopps Wagner Senior Vice President and General Counsel 24093 1Assurant Health Names Jennifer Kopps Wagner Senior Vice President and General Counsel 24093 2First Ever National Biovigilance Network in the U S Reaches 241 Million in Funding Prepares for Fall Pilot Launch 24088 1First Ever National Biovigilance Network in the U S Reaches 241 Million in Funding Prepares for Fall Pilot Launch 24088 2First Ever National Biovigilance Network in the U S Reaches 241 Million in Funding Prepares for Fall Pilot Launch 24088 3First Ever National Biovigilance Network in the U S Reaches 241 Million in Funding Prepares for Fall Pilot Launch 24088 4First Ever National Biovigilance Network in the U S Reaches 241 Million in Funding Prepares for Fall Pilot Launch 24088 5PAREXEL Promotes Dr Mark A Goldberg to Chief Operating Officer 6582 1PAREXEL Promotes Dr Mark A Goldberg to Chief Operating Officer 6582 2PAREXEL Promotes Dr Mark A Goldberg to Chief Operating Officer 6582 3PAREXEL Promotes Dr Mark A Goldberg to Chief Operating Officer 6582 4
...r all its promise, the prospect of using nanoparti...cts has raised concerns about possible harmful eff... University of Michigan are addressing those conce...icles damage cell membranes---enough to cause cell...revented. , "If you,re inventing these sorts of ma...
...ees in the world¹s most productive forests -- fore... tend to die young, according to a U.S. Geological...f the journal Ecology Letters. This discovery coul... to ongoing and future environmental changes. , "O...the world¹s most productive forests may be those l...
...ltiple sclerosis (MS) can be an unpredictable dise...acks healthy nerve cells and disrupts normal nerve...mptoms—including tingling, paralysis, pain, fatigu...y or in combination, sporadically or persistently....flare-ups are common in the majority of patients. ...
...number of articles explore the use of positron emi...onsurgical techniques that open the door to unders...issue of the Society of Nuclear Medicine,s Journal...nimal imaging "is the ability to carry out many st..." said SNM member Michael J. Welch, Ph.D., co-auth...
Other Biology News:Probing the promise and perils of nanoparticles 2Live fast, die young true for forests too 2Gene Signatures Predict Interferon Response For Multiple Sclerosis Patients 2Use of PET can reduce, may eliminate more strenuous drug development trials with animals 2Use of PET can reduce, may eliminate more strenuous drug development trials with animals 3Use of PET can reduce, may eliminate more strenuous drug development trials with animals 4
...al Stem Cell Functional Identification Kit contain...n be used for the short-term maintenance, differen...f NSCs into astrocyte, neuron and oligodendrocyte ...ti-human Nestin, mouse anti-human Glial Fibrillary...
Anti-Mouse MIP-1g, Biotin (Polyclonal) (rabbit IgG)
KNP-1 (HES1) Purified Anti-Mouse, Anti-Rat, Anti-Human, Anti-Dog, Anti-Chicken clone 35, Isotype Mouse IgG 1 , 150 µg Consult technical datasheet for details.
Request Info
Biology Products: